testosterone suspension cycle

Tradename:

testosterone suspension cycle

International nonproprietary name:

dexamethasone

Dosage Form:

eye drops

Description : Clear colorless solution.

Composition for 1 ml:

active substance: dexamethasone sodium phosphate (calculated as 100% solids) – 1 mg Other ingredients: boric acid – 15 mg of sodium tetraborate decahydrate – 0.6 mg disodium edetate dihydrate – 0.5 mg benzalkonium chloride -0 04 mg water for injection – up to 1 ml.

Pharmacotherapeutic group:

Glucocorticosteroids for local use.

Indications

Conjunctivitis (purulent and allergic), keratitis, keratoconjunctivitis (without damage to the epithelium), blepharitis, scleritis, episcleritis, iritis, iridocyclitis and other uveitis of various origins, Blepharoconjunctivitis, superficial injuries of different etiologies of the cornea (after complete epithelialization of the cornea), inflammation prevention after eye injury and surgical interventions, sympathetic ophthalmia.

Contraindications

Hypersensitivity to the drug, viral and fungal diseases of the eye, purulent eye infections (without concomitant antimicrobial therapy), trachoma, glaucoma, damage to the integrity of the corneal epithelium (including the state after the removal of corneal foreign body), tuberculosis, eye, children’s age (up to 18 years).

Application of pregnancy and during breastfeeding

During pregnancy, the drug is used with caution and only in those cases where the intended benefits to the mother outweighs the potential risk to the fetus. During lactation acceptable therapy for no more than 7-10 days.

Dosing and Administration

In the presence of the inflammatory process: during the first 24-48 hours of treatment 1-2 drops instilled in the conjunctival sac of each eye after 1-2 hours; after improvement (at stihanii inflammation) – every 4-6 hours.
For the prevention of inflammatory processes after eye surgery or injury: for the first 24 hours after surgery – 1-2 drops 4 times a day, then – 3 times per day . for 2 weeks
treatment course selected individually in average – 2-5 weeks.

Side effect

Immediately after instillation of possible short-term burning sensation, tearing, conjunctival hyperemia.
With prolonged use of eye drops (over 10 days) may increase intraocular pressure, glaucoma with damage to the optic nerve, blurred vision and loss of portions of the visual fields, and posterior subcapsular cataract formation it is also possible thinning and perforation of the cornea; the spread of herpes and bacterial infections.
In patients with hypersensitivity to dexamethasone, or benzalkonium chloride may develop allergic conjunctivitis and blepharitis.

Overdose

Symptoms: possible local reactions (transient burning sensation, tearing, conjunctival hyperemia). Treatment: removal of the drug, symptomatic therapy (no specific antidote).

Interaction with other drugs

Prolonged use may increase with idoxuridine destructive processes in the epithelium of the cornea.

special instructions

During the treatment of ophthalmic diseases (with a duration of more than 2 weeks) after 10 days requires monitoring of intraocular pressure and corneal condition.
If eye drops soft contact lenses must be removed and re-set no earlier than 15-20 minutes.
Treatment with a picture may mask bacterial or fungal infections, so the treatment of infectious eye diseases drug to be combined with appropriate antimicrobial therapy.
prolonged use should monitor the status of the cornea and the intraocular pressure.

Effects on ability to drive vehicles and management of potentially dangerous machinery : for 30 minutes after instillation of the drug should refrain from driving vehicles as possible short-term disturbance of visual acuity and lacrimation.

release Form

Drops eye 0.1%.
According to the 10 ml sterile plastic dropper bottles sealed polymer-plugs screw-caps and droppers.
In 10 ml sterile plastic dropper bottles, made by technology “blow-fill-seal” ¬ęblowing – filling -. sealing “hermetically sealed lids screw-
on 1 polymer dropper bottle with instruction on use is placed in a pile of cardboard or opaque polymer unit blister type Flow-Pack of polyvinyl chloride (PVC) with a flat substrate of aluminum foil printing patent or cardboard. injection winstrol